Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 06, 2016 6:55 PM ET


Company Overview of Endo Pharmaceuticals Solutions Inc.

Company Overview

Endo Pharmaceuticals Solutions Inc. develops products to treat conditions in urology and endocrinology in the United States. The company’s approved products consist SANCTURA, a muscarinic receptor antagonist, and SANCTURA XR for the treatment of overactive bladder that are co-promoted with its partner Allergan, Inc.; VANTAS for treating advanced prostate cancer; SUPPRELIN LA for central precocious puberty; and DELATESTRYL for the treatment of hypogonadism. Its urology and endocrinology development portfolio contains multiple compounds, which comprise NEBIDO for hypogonadism; VALSTAR for bladder cancer; PRO 2000 for the prevention of infection by HIV and other sexually-transmitted diseases; t...

100 Endo Boulevard

Chadds Ford, PA 19317

United States

Founded in 1988

246 Employees





Key Executives for Endo Pharmaceuticals Solutions Inc.

Chief Legal Officer, Executive Vice President, and Secretary
Age: 46
Compensation as of Fiscal Year 2015.

Endo Pharmaceuticals Solutions Inc. Key Developments

Cipla Plans To Acquire US-Based Companies

Cipla Limited (BSE:500087) is reportedly in talks to acquire US-based companies. Sources indicated that Cipla is in talks to acquire companies with large manufacturing units in generics, respiratory and oncology spaces. The acquisition size is likely to be around $200-300 million. Cipla is said to be targeting Indigo Pharmaceuticals, Inc. and Endo Pharmaceuticals Solutions Inc.

Similar Private Companies By Industry

Company Name Region
Barbeau Pharma, Inc. United States
Sulfagenix Inc. United States
China Yongxin Pharmaceuticals, Inc. United States
Bryce Rx Laboratories, Inc. United States
Amylyx Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Endo Pharmaceuticals Solutions Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at